1. Home
  2. GDV vs WVE Comparison

GDV vs WVE Comparison

Compare GDV & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gabelli Dividend & Income Trust of Beneficial Interest

GDV

Gabelli Dividend & Income Trust of Beneficial Interest

N/A

Current Price

$27.60

Market Cap

2.5B

Sector

Finance

ML Signal

N/A

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

N/A

Current Price

$13.25

Market Cap

2.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GDV
WVE
Founded
2003
2012
Country
United States
Singapore
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.4B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
GDV
WVE
Price
$27.60
$13.25
Analyst Decision
Strong Buy
Analyst Count
0
15
Target Price
N/A
$30.87
AVG Volume (30 Days)
126.0K
2.2M
Earning Date
01-01-0001
05-29-2026
Dividend Yield
5.81%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$3,704,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$119.93
P/E Ratio
N/A
N/A
Revenue Growth
N/A
149.43
52 Week Low
$20.10
$5.28
52 Week High
$29.46
$21.73

Technical Indicators

Market Signals
Indicator
GDV
WVE
Relative Strength Index (RSI) 27.47 47.06
Support Level $26.26 $12.53
Resistance Level $28.85 $14.56
Average True Range (ATR) 0.38 0.79
MACD -0.19 -0.04
Stochastic Oscillator 20.98 26.10

Price Performance

Historical Comparison
GDV
WVE

About GDV Gabelli Dividend & Income Trust of Beneficial Interest

Gabelli Dividend & Income Trust operates as a diversified closed-end management investment company. The fund's investment objective is to provide a high level of total return on its assets with an emphasis on dividends and income. To achieve its objective, the fund may invest its assets in dividend-paying securities or other income-producing securities. The fund invests in various sectors, in which Financial Services, Food and Beverage, Health Care, Consumer Products, Electronics, and Computer Software & Services and others.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: